Univariable and multivariable analyses for risk factors of failure endpoint in patients treated with tocilizumab and/or methylprednisolone and Standard Of Care (SOC).

NIAID Data Ecosystem20

Phase III Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R With Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas

弥漫性大B细胞淋巴瘤

化疗方案疗效比较

This randomized phase III trial studies rituximab when given together with two different combination chemotherapy regimens to compare how well they work in treating patients with diffuse large B-cel

DataCite Commons2026-01-15 更新00

The Surprise Study dataset

临床预后预测

姑息治疗评估

An international comparison of the Surprise Question

NIAID Data Ecosystem30

Univariate and multivariate analysis of prognostic factors for 264 patients with GLM.

乳腺炎预后分析

临床预后预测

Univariate and multivariate analysis of prognostic factors for 264 patients with GLM.

NIAID Data Ecosystem10